Cytokinetics Inc (CYTK)

Financial leverage ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total assets	US$ in thousands	1,401,670	824,316	1,014,780	841,319	533,803
Total stockholders’ equity	US$ in thousands	-135,372	-386,323	-107,900	243,863	113,383
Financial leverage ratio		—	—	—	3.45	4.71

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,401,670K ÷ $-135,372K
= —

The financial leverage ratio of Cytokinetics Inc has shown a decreasing trend over the past few years. As of December 31, 2020, the ratio was relatively high at 4.71, indicating a higher level of financial leverage and potential financial risk. However, by December 31, 2021, the ratio decreased to 3.45, suggesting a reduction in the company's reliance on debt financing compared to its equity.

The absence of data for the years 2022, 2023, and 2024 makes it challenging to assess the company's current financial leverage position accurately. It is important to note that a declining trend in financial leverage ratio generally signifies improved financial stability and a lower risk of default for the company. Further analysis would be required to understand the reasons behind the changes in the financial leverage ratio and to evaluate the impact on Cytokinetics Inc's overall financial health and performance.